Filing Details
- Accession Number:
- 0001349929-14-000017
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-12-15 18:50:10
- Reporting Period:
- 2014-12-11
- Filing Date:
- 2014-12-15
- Accepted Time:
- 2014-12-15 18:50:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1349929 | Cancer Genetics Inc | CGIX | Services-Medical Laboratories (8071) | 043462475 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1603489 | J Edward Sitar | 201 Route 17 North, 2Nd Floor C/O Cancer Genetics, Inc. Rutherford NJ 07070 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.0001 Per Share | Acquisiton | 2014-12-12 | 500 | $6.26 | 11,500 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Acquisiton | 2014-12-11 | 90,000 | $0.00 | 90,000 | $6.30 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 90,000 | 2024-12-10 | No | 4 | A | Direct |
Footnotes
- Options vest twenty percent on the date of grant, with subsequent vesting in equal installments over the following forty-eight months.
Billionaire Hedge Funds
